Annual Cost Of Goods Sold
$1.26 B
+$181.90 M+16.84%
31 December 2023
Summary:
Vertex Pharmaceuticals Incorporated annual cost of goods sold is currently $1.26 billion, with the most recent change of +$181.90 million (+16.84%) on 31 December 2023. During the last 3 years, it has risen by +$525.90 million (+71.42%). VRTX annual cost of goods sold is now at all-time high.VRTX Cost Of Goods Sold Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cost Of Goods Sold
$392.60 M
+$20.70 M+5.57%
30 September 2024
Summary:
Vertex Pharmaceuticals Incorporated quarterly cost of goods sold is currently $392.60 million, with the most recent change of +$20.70 million (+5.57%) on 30 September 2024. Over the past year, it has increased by +$73.90 million (+23.19%). VRTX quarterly cost of goods sold is now at all-time high.VRTX Quarterly Cost Of Goods Sold Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Cost Of Goods Sold
$1.48 B
+$73.90 M+5.27%
30 September 2024
Summary:
Vertex Pharmaceuticals Incorporated TTM cost of goods sold is currently $1.48 billion, with the most recent change of +$73.90 million (+5.27%) on 30 September 2024. Over the past year, it has increased by +$297.60 million (+25.27%). VRTX TTM cost of goods sold is now at all-time high.VRTX TTM Cost Of Goods Sold Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VRTX Cost Of Goods Sold Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +16.8% | +23.2% | +25.3% |
| 3 y3 years | +71.4% | +66.0% | +71.5% |
| 5 y5 years | +208.2% | +197.6% | +204.1% |
VRTX Cost Of Goods Sold High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +71.4% | at high | +66.0% | at high | +71.5% |
| 5 y | 5 years | at high | +208.2% | at high | +197.6% | at high | +204.1% |
| alltime | all time | at high | >+9999.0% | at high | +1619.2% | at high | >+9999.0% |
Vertex Pharmaceuticals Incorporated Cost Of Goods Sold History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $392.60 M(+5.6%) | $1.48 B(+5.3%) |
| June 2024 | - | $371.90 M(+8.6%) | $1.40 B(+4.7%) |
| Mar 2024 | - | $342.60 M(-6.9%) | $1.34 B(+6.0%) |
| Dec 2023 | $1.26 B(+16.8%) | $368.00 M(+15.5%) | $1.26 B(+7.2%) |
| Sept 2023 | - | $318.70 M(+3.3%) | $1.18 B(+2.6%) |
| June 2023 | - | $308.60 M(+15.6%) | $1.15 B(+4.2%) |
| Mar 2023 | - | $266.90 M(-5.8%) | $1.10 B(+2.0%) |
| Dec 2022 | $1.08 B(+19.5%) | $283.30 M(-2.1%) | $1.08 B(+3.4%) |
| Sept 2022 | - | $289.40 M(+10.5%) | $1.04 B(+5.3%) |
| June 2022 | - | $261.80 M(+6.5%) | $991.50 M(+3.5%) |
| Mar 2022 | - | $245.80 M(-0.6%) | $957.70 M(+5.9%) |
| Dec 2021 | $904.20 M(+22.8%) | $247.40 M(+4.6%) | $904.20 M(+5.2%) |
| Sept 2021 | - | $236.50 M(+3.7%) | $859.90 M(+6.2%) |
| June 2021 | - | $228.00 M(+18.6%) | $809.58 M(+5.7%) |
| Mar 2021 | - | $192.30 M(-5.3%) | $766.10 M(+4.0%) |
| Dec 2020 | $736.30 M(+34.4%) | $203.10 M(+9.1%) | $736.30 M(+2.5%) |
| Sept 2020 | - | $186.18 M(+0.9%) | $718.25 M(+8.2%) |
| June 2020 | - | $184.52 M(+13.6%) | $663.99 M(+7.9%) |
| Mar 2020 | - | $162.50 M(-12.2%) | $615.21 M(+12.3%) |
| Dec 2019 | $547.80 M(+33.8%) | $185.05 M(+40.3%) | $547.80 M(+12.9%) |
| Sept 2019 | - | $131.91 M(-2.8%) | $485.04 M(+4.4%) |
| June 2019 | - | $135.74 M(+42.7%) | $464.38 M(+7.2%) |
| Mar 2019 | - | $95.09 M(-22.2%) | $433.02 M(+5.7%) |
| Dec 2018 | $409.54 M(+48.9%) | $122.29 M(+9.9%) | $409.54 M(+10.3%) |
| Sept 2018 | - | $111.25 M(+6.6%) | $371.30 M(+11.5%) |
| June 2018 | - | $104.38 M(+45.8%) | $332.92 M(+11.1%) |
| Mar 2018 | - | $71.61 M(-14.8%) | $299.74 M(+9.0%) |
| Dec 2017 | $275.12 M(+30.7%) | $84.05 M(+15.3%) | $275.12 M(+9.4%) |
| Sept 2017 | - | $72.87 M(+2.3%) | $251.55 M(+8.1%) |
| June 2017 | - | $71.20 M(+51.5%) | $232.75 M(+12.5%) |
| Mar 2017 | - | $46.99 M(-22.3%) | $206.80 M(-1.7%) |
| Dec 2016 | $210.46 M(+69.0%) | $60.48 M(+11.8%) | $210.46 M(-1.4%) |
| Sept 2016 | - | $54.08 M(+19.5%) | $213.36 M(+11.6%) |
| June 2016 | - | $45.25 M(-10.7%) | $191.25 M(+17.4%) |
| Mar 2016 | - | $50.65 M(-20.1%) | $162.85 M(+30.8%) |
| Dec 2015 | $124.51 M(+104.2%) | $63.38 M(+98.3%) | $124.51 M(+65.7%) |
| Sept 2015 | - | $31.96 M(+89.6%) | $75.15 M(+31.0%) |
| June 2015 | - | $16.86 M(+37.0%) | $57.38 M(-0.8%) |
| Mar 2015 | - | $12.31 M(-12.3%) | $57.82 M(-5.2%) |
| Dec 2014 | $60.99 M(-53.2%) | $14.03 M(-1.1%) | $60.99 M(-11.9%) |
| Sept 2014 | - | $14.18 M(-18.0%) | $69.22 M(-16.0%) |
| June 2014 | - | $17.30 M(+11.8%) | $82.38 M(-20.0%) |
| Mar 2014 | - | $15.48 M(-30.5%) | $103.01 M(-20.9%) |
| Dec 2013 | $130.28 M(-53.5%) | $22.26 M(-18.6%) | $130.28 M(-33.4%) |
| Sept 2013 | - | $27.34 M(-27.9%) | $195.73 M(-5.4%) |
| June 2013 | - | $37.93 M(-11.3%) | $206.93 M(-27.0%) |
| Mar 2013 | - | $42.74 M(-51.3%) | $283.42 M(+1.3%) |
| Dec 2012 | $279.88 M(+247.7%) | $87.72 M(+127.6%) | $279.88 M(+25.9%) |
| Sept 2012 | - | $38.54 M(-66.3%) | $222.30 M(+0.1%) |
| June 2012 | - | $114.42 M(+191.8%) | $222.17 M(+89.8%) |
| Mar 2012 | - | $39.21 M(+30.2%) | $117.05 M(+45.4%) |
| Dec 2011 | $80.50 M(+532.4%) | $30.13 M(-21.6%) | $80.50 M(+50.7%) |
| Sept 2011 | - | $38.41 M(+312.7%) | $53.43 M(+192.8%) |
| June 2011 | - | $9.31 M(+249.1%) | $18.25 M(+51.7%) |
| Mar 2011 | - | $2.67 M(-12.6%) | $12.03 M(-5.5%) |
| Dec 2010 | $12.73 M(-10.4%) | $3.05 M(-5.5%) | $12.73 M(-4.5%) |
| Sept 2010 | - | $3.23 M(+4.6%) | $13.33 M(-3.5%) |
| June 2010 | - | $3.09 M(-8.3%) | $13.81 M(-1.3%) |
| Mar 2010 | - | $3.37 M(-7.7%) | $13.99 M(-1.5%) |
| Dec 2009 | $14.20 M(-9.5%) | $3.65 M(-1.8%) | $14.20 M(-3.8%) |
| Sept 2009 | - | $3.71 M(+13.6%) | $14.77 M(-3.2%) |
| June 2009 | - | $3.27 M(-8.6%) | $15.25 M(-2.8%) |
| Mar 2009 | - | $3.58 M(-15.2%) | $15.69 M(0.0%) |
| Dec 2008 | $15.69 M(+12.8%) | $4.21 M(+0.5%) | $15.69 M(+3.6%) |
| Sept 2008 | - | $4.19 M(+13.3%) | $15.14 M(+4.4%) |
| June 2008 | - | $3.70 M(+3.5%) | $14.51 M(+2.1%) |
| Mar 2008 | - | $3.58 M(-2.6%) | $14.21 M(+2.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2007 | $13.90 M(+14.2%) | $3.67 M(+3.1%) | $13.90 M(+3.7%) |
| Sept 2007 | - | $3.56 M(+4.7%) | $13.41 M(+3.5%) |
| June 2007 | - | $3.40 M(+4.0%) | $12.96 M(+4.1%) |
| Mar 2007 | - | $3.27 M(+2.9%) | $12.44 M(+2.3%) |
| Dec 2006 | $12.17 M(+20.5%) | $3.18 M(+2.1%) | $12.17 M(+3.3%) |
| Sept 2006 | - | $3.11 M(+7.9%) | $11.78 M(+2.8%) |
| June 2006 | - | $2.88 M(-3.7%) | $11.46 M(+3.6%) |
| Mar 2006 | - | $3.00 M(+7.6%) | $11.06 M(+9.6%) |
| Dec 2005 | $10.10 M(+78.8%) | $2.78 M(-0.5%) | $10.10 M(+8.3%) |
| Sept 2005 | - | $2.80 M(+12.3%) | $9.32 M(+16.6%) |
| June 2005 | - | $2.49 M(+22.6%) | $7.99 M(+17.0%) |
| Mar 2005 | - | $2.03 M(+1.0%) | $6.83 M(+21.0%) |
| Dec 2004 | $5.65 M(+80.7%) | $2.01 M(+37.0%) | $5.65 M(+21.5%) |
| Sept 2004 | - | $1.47 M(+10.4%) | $4.65 M(+16.8%) |
| June 2004 | - | $1.33 M(+57.0%) | $3.98 M(-5.0%) |
| Mar 2004 | - | $846.00 K(-16.2%) | $4.19 M(-38.9%) |
| Dec 2003 | $3.13 M(-6.2%) | $1.01 M(+26.6%) | $6.86 M(-154.9%) |
| Sept 2003 | - | $797.00 K(-48.2%) | -$12.50 M(+86.1%) |
| June 2003 | - | $1.54 M(-56.2%) | -$6.72 M(+274.8%) |
| Mar 2003 | - | $3.52 M(-119.2%) | -$1.79 M(-153.7%) |
| Dec 2002 | $3.33 M(-7.2%) | -$18.35 M(-378.9%) | $3.33 M(-180.1%) |
| Sept 2002 | - | $6.58 M(+1.8%) | -$4.16 M(+2137.6%) |
| June 2002 | - | $6.46 M(-25.2%) | -$186.00 K(-96.8%) |
| Mar 2002 | - | $8.64 M(-133.4%) | -$5.73 M(-57.7%) |
| Dec 2001 | $3.59 M(-92.3%) | -$25.84 M(-344.9%) | -$13.53 M(-121.6%) |
| Sept 2001 | - | $10.55 M(+1045.8%) | $62.52 M(+23.1%) |
| June 2001 | - | $921.00 K(+10.0%) | $50.80 M(+4.0%) |
| Mar 2001 | - | $837.00 K(-98.3%) | $48.87 M(+4.1%) |
| Dec 2000 | $46.93 M(-1480.3%) | $50.21 M(-4402.5%) | $46.93 M(-1196.5%) |
| Sept 2000 | - | -$1.17 M(+15.5%) | -$4.28 M(+4.1%) |
| June 2000 | - | -$1.01 M(-8.4%) | -$4.11 M(+23.9%) |
| Mar 2000 | - | -$1.10 M(+10.3%) | -$3.32 M(-2.8%) |
| Dec 1999 | -$3.40 M(-24.4%) | -$1.00 M(0.0%) | -$3.42 M(-10.5%) |
| Sept 1999 | - | -$1.00 M(+360.8%) | -$3.82 M(-2.6%) |
| June 1999 | - | -$217.00 K(-81.9%) | -$3.92 M(-18.4%) |
| Mar 1999 | - | -$1.20 M(-14.3%) | -$4.80 M(+6.7%) |
| Dec 1998 | -$4.50 M(+25.0%) | -$1.40 M(+27.3%) | -$4.50 M(+9.8%) |
| Sept 1998 | - | -$1.10 M(0.0%) | -$4.10 M(+2.5%) |
| June 1998 | - | -$1.10 M(+22.2%) | -$4.00 M(+8.1%) |
| Mar 1998 | - | -$900.00 K(-10.0%) | -$3.70 M(+2.8%) |
| Dec 1997 | -$3.60 M(+12.5%) | -$1.00 M(0.0%) | -$3.60 M(+9.1%) |
| Sept 1997 | - | -$1.00 M(+25.0%) | -$3.30 M(+6.5%) |
| June 1997 | - | -$800.00 K(0.0%) | -$3.10 M(-3.1%) |
| Mar 1997 | - | -$800.00 K(+14.3%) | -$3.20 M(0.0%) |
| Dec 1996 | -$3.20 M(-13.5%) | -$700.00 K(-12.5%) | -$3.20 M(-8.6%) |
| Sept 1996 | - | -$800.00 K(-11.1%) | -$3.50 M(-5.4%) |
| June 1996 | - | -$900.00 K(+12.5%) | -$3.70 M(+5.7%) |
| Mar 1996 | - | -$800.00 K(-20.0%) | -$3.50 M(-5.4%) |
| Dec 1995 | -$3.70 M(+5.7%) | -$1.00 M(0.0%) | -$3.70 M(0.0%) |
| Sept 1995 | - | -$1.00 M(+42.9%) | -$3.70 M(+5.7%) |
| June 1995 | - | -$700.00 K(-30.0%) | -$3.50 M(-5.4%) |
| Mar 1995 | - | -$1.00 M(0.0%) | -$3.70 M(+2.8%) |
| Dec 1994 | -$3.50 M(-10.3%) | -$1.00 M(+25.0%) | -$3.60 M(-2.7%) |
| Sept 1994 | - | -$800.00 K(-11.1%) | -$3.70 M(-2.6%) |
| June 1994 | - | -$900.00 K(0.0%) | -$3.80 M(0.0%) |
| Mar 1994 | - | -$900.00 K(-18.2%) | -$3.80 M(+2.7%) |
| Dec 1993 | -$3.90 M(+39.3%) | -$1.10 M(+22.2%) | -$3.70 M(+12.1%) |
| Sept 1993 | - | -$900.00 K(0.0%) | -$3.30 M(+6.5%) |
| June 1993 | - | -$900.00 K(+12.5%) | -$3.10 M(+1450.0%) |
| Mar 1993 | - | -$800.00 K(+14.3%) | -$200.00 K(<-9900.0%) |
| Dec 1992 | -$2.80 M(+55.6%) | -$700.00 K(0.0%) | $0.00(-100.0%) |
| Sept 1992 | - | -$700.00 K(-135.0%) | $200.00 K(-60.0%) |
| June 1992 | - | $2.00 M(-433.3%) | $500.00 K(-125.0%) |
| Mar 1992 | - | -$600.00 K(+20.0%) | -$2.00 M(+42.9%) |
| Dec 1991 | -$1.80 M | -$500.00 K(+25.0%) | -$1.40 M(+55.6%) |
| Sept 1991 | - | -$400.00 K(-20.0%) | -$900.00 K(+80.0%) |
| June 1991 | - | -$500.00 K | -$500.00 K |
FAQ
- What is Vertex Pharmaceuticals Incorporated annual cost of goods sold?
- What is the all time high annual cost of goods sold for Vertex Pharmaceuticals Incorporated?
- What is Vertex Pharmaceuticals Incorporated annual cost of goods sold year-on-year change?
- What is Vertex Pharmaceuticals Incorporated quarterly cost of goods sold?
- What is the all time high quarterly cost of goods sold for Vertex Pharmaceuticals Incorporated?
- What is Vertex Pharmaceuticals Incorporated quarterly cost of goods sold year-on-year change?
- What is Vertex Pharmaceuticals Incorporated TTM cost of goods sold?
- What is the all time high TTM cost of goods sold for Vertex Pharmaceuticals Incorporated?
- What is Vertex Pharmaceuticals Incorporated TTM cost of goods sold year-on-year change?
What is Vertex Pharmaceuticals Incorporated annual cost of goods sold?
The current annual cost of goods sold of VRTX is $1.26 B
What is the all time high annual cost of goods sold for Vertex Pharmaceuticals Incorporated?
Vertex Pharmaceuticals Incorporated all-time high annual cost of goods sold is $1.26 B
What is Vertex Pharmaceuticals Incorporated annual cost of goods sold year-on-year change?
Over the past year, VRTX annual cost of goods sold has changed by +$181.90 M (+16.84%)
What is Vertex Pharmaceuticals Incorporated quarterly cost of goods sold?
The current quarterly cost of goods sold of VRTX is $392.60 M
What is the all time high quarterly cost of goods sold for Vertex Pharmaceuticals Incorporated?
Vertex Pharmaceuticals Incorporated all-time high quarterly cost of goods sold is $392.60 M
What is Vertex Pharmaceuticals Incorporated quarterly cost of goods sold year-on-year change?
Over the past year, VRTX quarterly cost of goods sold has changed by +$73.90 M (+23.19%)
What is Vertex Pharmaceuticals Incorporated TTM cost of goods sold?
The current TTM cost of goods sold of VRTX is $1.48 B
What is the all time high TTM cost of goods sold for Vertex Pharmaceuticals Incorporated?
Vertex Pharmaceuticals Incorporated all-time high TTM cost of goods sold is $1.48 B
What is Vertex Pharmaceuticals Incorporated TTM cost of goods sold year-on-year change?
Over the past year, VRTX TTM cost of goods sold has changed by +$297.60 M (+25.27%)